Leadership & Pay ·
Avalo Therapeutics, Inc. appointed Ron Philip to its Board of Directors, effective June 23, 2026
AVTXAvalo Therapeutics, Inc.
Avalo Therapeutics, Inc. appointed Ron Philip to its Board of Directors, effective June 23, 2026. Mr. Philip will serve on the Compensation Committee and the Science, Development and Commercial Advisory Committee until the 2027 Annual Meeting of Stockholders. As part of his appointment, he will receive a non-qualified stock option to purchase 40,200 shares of common stock, vesting in three equal annual installments. Mr. Philip previously held leadership roles at Spark Therapeutics, Orbital Therapeutics, and Pfizer. Avalo Therapeutics, Inc. is a biotechnology company.